Advertisement

Critical Illness and Delirium

  • Valerie PageEmail author
  • Tamas Bakonyi
Chapter
Part of the In Clinical Practice book series (ICP)

Abstract

Delirium is common in critically ill patients, it is distressing, difficult to diagnose and leads to long-term adverse outcomes. It is essential that critical care clinicians take it seriously, diagnose it, manage the causes and reduce the risk factors.

Keywords

ICU delirium Diagnosis Haloperidol 

References

  1. 1.
    Mehta S, Cook D, Devlin JW, et al. Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults. Crit Care Med. 2015;43:557–66.CrossRefGoogle Scholar
  2. 2.
    Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369:1306–16.CrossRefGoogle Scholar
  3. 3.
    Vasilevskis E, Holtz C, Girard T, et al. The cost of delirium in the intensive care unit: attributable costs of care intensity and mortality [abstract]. J Hosp Med. 2015;10(Suppl 2). Accessed 29 Mar 2017.Google Scholar
  4. 4.
    Barr J, Fraser GL, Puntillo K, et al. American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.CrossRefGoogle Scholar
  5. 5.
    Cerejeira J, Nogueira V, Luís P, Vaz-Serra A, Mukaetova-Ladinska EB. The cholinergic system and inflammation: common pathways in delirium pathophysiology. J Am Geriatr Soc. 2012;60:669–75.CrossRefGoogle Scholar
  6. 6.
    Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132–48.PubMedGoogle Scholar
  7. 7.
    Gunther ML, Morandi A, Krauskopf E, et al. VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae. The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study. Crit Care Med. 2012;40(7):2022–32.Google Scholar
  8. 8.
    Stagno D, Gibson C, Breitbart W. The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care. 2004;2:171–9.CrossRefGoogle Scholar
  9. 9.
    Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, Ely EW. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54:479–84.CrossRefGoogle Scholar
  10. 10.
    Boettger S, Nuñez DG, Meyer R, et al. Brief assessment of delirium subtypes: psychometric evaluation of the delirium motor subtype scale (DMSS)-4 in the intensive care setting. Palliat Support Care. 2017;15:535–43.CrossRefGoogle Scholar
  11. 11.
    Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29(7):1370–9.CrossRefGoogle Scholar
  12. 12.
    Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27(5):859–64.CrossRefGoogle Scholar
  13. 13.
    Patel SB, Poston JT, Pohlman A, et al. Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med. 2014;189:658–65.CrossRefGoogle Scholar
  14. 14.
    Han JH, Wilson A, Vasilevskis EE, et al. Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method. Ann Emerg Med. 2013;62(5):457–65.CrossRefGoogle Scholar
  15. 15.
    O’Regan N, Ryan DJ, Boland E, et al. Attention! A good bedside test for delirium? J Neurol Neurosurg Psychiatry. 2014;85:1122–31.CrossRefGoogle Scholar
  16. 16.
    van der Kooi AW, Slooter AJC. EEG in delirium: increased spectral variability and decreased complexity. Clin Neurophysiol. 2014 Oct;125(10):2137–9.CrossRefGoogle Scholar
  17. 17.
    van der Kooi AW, Zaal IJ, Klijn AF, et al. Delirium detection using EEG: what and how to measure. Chest. 2015;147:94–101.CrossRefGoogle Scholar
  18. 18.
    Green C, Hendry K, Wilson ES, et al. A novel computerized test for detecting and monitoring visual attentional deficits and delirium in the ICU. Crit Care Med. 2017;45:1224–31.CrossRefGoogle Scholar
  19. 19.
    Hein C, Forgues A, Piau A, et al. Impact of polypharmacy on occurrence of delirium in elderly emergency patients. J Am Med Dir Assoc. 2014;15:850.311–5.CrossRefGoogle Scholar
  20. 20.
    Siddiqi N, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, Simpkins SA. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016;(3):CD005563.  https://doi.org/10.1002/14651858.CD005563.pub3.
  21. 21.
    Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373:1874–8.CrossRefGoogle Scholar
  22. 22.
    Whitehouse T, Snelson C, Grounds M. Intensive Care Society review of best practice for analgesia and sedation in the Critical Care 2014. https://www.ics.ac.uk/ICS/guidelines-and-standards.aspx. Last accessed 11 Sept 2017.
  23. 23.
    Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.CrossRefGoogle Scholar
  24. 24.
    Celis-Rodríguez E, Birchenall C, de la Cal MÁ, et al. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Federación Panamericana e Ibérica de Sociedades de Medicina Crítica y Terapia Intensiva. Med Intensiva. 2013;37:519–74.CrossRefGoogle Scholar
  25. 25.
    DAS-Taskforce 2015, Baron R, Binder A, et al. Evidence and consensus based guideline for the management of delirium, analgesia and sedation in intensive care medicine. Revision 2015 (DAS-guideline 2015) – short version. Ger Med Sci. 2015;13:Doc19.Google Scholar
  26. 26.
    Vincent JL, Shehabi Y, Walsh TS. Comfort and patient-centred care without excessive sedation: the eCASH concept. Intensive Care Med. 2016;42(6):962–71.CrossRefGoogle Scholar
  27. 27.
    Everingham K, Fawcett T, Walsh T. ‘Targeting’ sedation: the lived experience of the intensive care nurse. J Clin Nurs. 2014;23:694–703.CrossRefGoogle Scholar
  28. 28.
    Sneyers B, Laterre P-F, Perreault MM, Wouters D, Spinewine A, et al. Current practices and barriers impairing physicians’ and nurses’ adherence to analgo-sedation recommendations in the intensive care unit – a national survey. Crit Care. 2014;18:655.CrossRefGoogle Scholar
  29. 29.
    Sneyers B, Laterre PF, Bricq E, Perreault MM, Wouters D, Spinewine A. What stops us from following sedation recommendations in intensive care unit? A multicentric qualitative study. J Crit Care. 2014;29:291–7.CrossRefGoogle Scholar
  30. 30.
    Zaal IJ, Devlin JW, Hazelbag M, et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med. 2015;41:2130–7.CrossRefGoogle Scholar
  31. 31.
    Lonardo NW, Mone MC, Nirula R, et al. Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med. 2014s;189:1383–94.CrossRefGoogle Scholar
  32. 32.
    Mo Y, Zimmermann AE. Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients. Ann Pharmacother. 2013;47:869–76.CrossRefGoogle Scholar
  33. 33.
    Jakob SM, Roukonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or Propofol for sedation during prolonged mechanical ventilation two randomized controlled trials. JAMA. 2012;307(11):1151–60.CrossRefGoogle Scholar
  34. 34.
    Reade MC, Eastwood GM, Bellomo R, et al. Effect of Dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA. 2016;315:1460–8.CrossRefGoogle Scholar
  35. 35.
    Richards-Belle A, Canter RR, Power GA, et al. National survey and point prevalence study of sedation practice in UK critical care. Crit Care. 2016;20:355.CrossRefGoogle Scholar
  36. 36.
    Wolters AE, Zaal IJ, Veldhuijzen DS, et al. Anticholinergic medication use and transition to delirium in critically ill patients: a prospective cohort study. Crit Care Med. 2015;43:1846–52.CrossRefGoogle Scholar
  37. 37.
    Schreiber MP, Colantuoni E, Neufeld KJ, Needham DM. Comparing analyses of corticosteroids and transition to delirium in critically ill patients. Intensive Care Med. 2017;43:1933–5.CrossRefGoogle Scholar
  38. 38.
    Dieleman JM, Nierich AP, Rosseel PM, et al. Dexamethasone for cardiac surgery study group (2012) intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761–7.CrossRefGoogle Scholar
  39. 39.
    Keh D, Marx ETG, et al. Effect of hydrocortisone on development of shock among patients with severe SepsisThe HYPRESS randomized clinical. Trial JAMA. 2016;316:1775–85.CrossRefGoogle Scholar
  40. 40.
    MacSweeney R, Barber V, Page V, et al. A national survey of the management of delirium in UK intensive care units. QJM. 2010;103:243–51.CrossRefGoogle Scholar
  41. 41.
    Page VJ, Ely EW, Gate S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1:515–23.CrossRefGoogle Scholar
  42. 42.
    Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017;13:161–75.CrossRefGoogle Scholar
  43. 43.
    National Institute for Health and Clinical Excellence. Delirium: prevention, diagnosis and management. NICE guideline (CG103). 2010.Google Scholar
  44. 44.
    Agar MR, Lawlor PG, Quinn S, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017;177:34–42.CrossRefGoogle Scholar
  45. 45.
    van Eijk MM, Roes KC, Honing ML, et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet. 2010;376:1829–37.CrossRefGoogle Scholar
  46. 46.
    Page VJ, Casarin A, Ely EW, et al. Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2017;5:727–37.CrossRefGoogle Scholar
  47. 47.
    Morandi A, Hughes CG, Thompson JL, et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med. 2014;42:1899–909.CrossRefGoogle Scholar
  48. 48.
    O’Sullivan R, Inouye SK, Meagher D. Delirium and depression: inter-relationship and clinical overlap in elderly people. Lancet Psychiatry. 2014;1:303–11.CrossRefGoogle Scholar
  49. 49.
    Svenningsen H. Associations between sedation, delirium and post-traumatic stress disorder and their impact on quality of life and memories following discharge from an intensive care unit. Dan Med J. 2013;60:B4630.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Anaesthesia and Critical CareWatford General HospitalWatfordUK
  2. 2.Imperial CollegeLondonUK
  3. 3.Intensive CareSt Mary’s HospitalLondonUK

Personalised recommendations